Cargando...
Immune checkpoint inhibitors and cellular treatment for lymphoma immunotherapy
Malignant lymphoma (ML) is a common hematological malignancy with many subtypes. Patients with ML usually undergo traditional treatment failure and become relapsed or refractory (R/R) cases. Recently, immunotherapy, such as immune checkpoint inhibitors (ICIs) and cellular treatment, has gradually em...
Gardado en:
| Publicado en: | Clin Exp Immunol |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
John Wiley and Sons Inc.
2021
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8209615/ https://ncbi.nlm.nih.gov/pubmed/33675535 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cei.13592 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|